Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.72 |
| ▸ | SLC5A1 | P13866 | 10/20 | 0.60 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | SLC5A11 | Q8WWX8 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17795 | 0.96 | SLC5A2 (0.69) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL19243 | 0.90 | SLC5A2 (0.61) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL18233 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL18369 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL17357 | 0.87 | SLC5A2 (0.59) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL17541 | 0.87 | SLC5A2 (0.59) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL17909 | 0.86 | SLC5A2 (0.73) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL18482 | 0.86 | SLC5A2 (0.73) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL17983 | 0.86 | SLC5A2 (0.69) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL27363337 | 0.84 | SLC5A2 (1.00) | SLC5A2SLC5A1ADRA2ASLC5A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |